Lippis Daniel J.'s Form 4 filing
Edwards Lifesciences Corp (EW) · filed Apr 6, 2026
- Accession no.
- 0001225208-26-004422
- Filed
- Apr 6, 2026
- Trade date
- Apr 6, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $82.5K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lippis Daniel J.CIK 0002004380 | Officer (CVP, TAVR) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Common Stock | MOption exerciseAcquired | +1,019 | $59.26 | +$60,385.94 | 34,952.91 | Direct | |
| Apr 6, 2026 | Common Stock | SSaleDisposed | −1,019 | $80.98 | −$82,518.62 | 33,933.91 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 | Common Stock | MOption exerciseDisposed | −1,019 | $0.00 | $0 | 2,038 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.